Patient Adherence, Communication and Engagement (PACE) -Increased Investment and Adoption of New Digital Tools EnableKey S...
- Key drivers in the healthcare landscape increasing health organizations’ focus and efforts onadherence- Implications for...
3.4.3 Shifting Gears - mHealth Leveraging Smart Phones and Personal Devices 263.4.4 Rising Prominence of Social Media and ...
1.1 List of TablesTable 1: PACE Industry Drivers, Challenges and Opportunities, 2012 11Table 2: PACE, % of Medicare FFS Be...
Figure 8: PACE, Beneficiary Interventions, The US, % of MTM Programs, 2010-2011 24Figure 9: PACE, Provider of MTM Services...
Upcoming SlideShare
Loading in …5
×

Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance

176 views
157 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
176
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance

  1. 1. Patient Adherence, Communication and Engagement (PACE) -Increased Investment and Adoption of New Digital Tools EnableKey Stakeholder Collaborations and Encourage ComplianceReport Details:Published:November 2012No. of Pages: 66Price: Single User License – US$3500Patient Adherence, Communication and Engagement (PACE) - Increased Investment andAdoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage ComplianceSummaryGBI Research, a leading business intelligence provider, has released its latest research, “PatientAdherence, Communication and Engagement (PACE) - Increased Investment and Adoption ofNew Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance”. The reportfocuses on the US health system’s efforts to improve patient engagement and medicationadherence. Key topics of the report include reforms in the US healthcare industry, technologyadoption, mobile and social media in healthcare, industry collaborations and examples of patientengagement and adherence interventions. There is a increasing focus on medication non-adherence as a critical challenge in the US healthcare system. When patients do not adhere totheir prescribed medication or treatment regimen, it leads to reduced efficiency of treatment andincreased utilization of care facilities. Healthcare expenditure is rising at an exponential rate,forcing the industry to focus on efficiencies in care delivery to control costs and improve healthoutcomes. Health insurance reforms and new payment and reimbursement models placeemphasis on outcome-based performance measures. Rising healthcare costs have providedimpetus to the health organizations to collaborate on their patient engagement interventions in aneffort to control the epidemic of non-adherence. Federal stimulus has increased adoption ofhealthcare information technology by the providers, and payers are also increasingly adoptinghealthcare technology. The integration of information systems across care facilities gives greateraccess to data and enables collaboration between different players in the industry. Health industryplayers leverage these systems and use this increased access to data, in combination with othertechnologies, to improve their patient engagement efforts.Scope
  2. 2. - Key drivers in the healthcare landscape increasing health organizations’ focus and efforts onadherence- Implications for industry stakeholders, pharmaceutical manufacturers, health plans andhealthcare providers- Examples of collaborative efforts within key stakeholder groups- Analysis of the key technology trends within the healthcare industry- Examples of adherence interventions that leverage technology to achieve their goalsReasons to buy- Understand how the changing healthcare landscape is influencing different stakeholder groups tofocus on patient engagement- Understand how industry players are forging collaborations with other organizations in theiradherence efforts- Explore the effectiveness of social media and mobile campaigns- Analyze existing healthcare technologies that support patient engagement efforts- Analyze existing engagement best practices in adherence efforts- Develop effective adherence interventions that leverage technology for patient outreachGet your copy of this report @http://www.reportsnreports.com/reports/208784-patient-adherence-communication-and-engagement-pace-increased-investment-and-adoption-of-new-digital-tools-enable-key-stakeholder-collaborations-and-encourage-compliance.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 51.1 List of Tables 61.2 List of Figures 72 Patient Adherence, Communication and Engagement (PACE) - Introduction 83 Patient Adherence, Communication and Engagement (PACE) - Market Dynamics 93.1 Medication Non-adherence Gains Industry-wide Attention 93.2 Key Trends in Healthcare Landscape Driving Investment in Adherence Programs 103.2.1 Change Drivers in the Healthcare Industry 103.2.2 Opportunities and Challenges in the New Healthcare Landscape 113.2.3 Healthcare Reform - Increasing Access and Improving Outcomes 123.2.4 Changing Priorities in Healthcare Landscape 143.2.5 HITECH - Outlined Criteria for Meaningful Use of EHRs 193.2.6 HHS Health Data Initiative - Accessible Data is Seen as a Change Driver in Healthcare 193.3 Implications for Pharmaceutical Industry 203.4 Trends Showing the Way Forward 213.4.1 Healthcare Technology Trends 213.4.2 Medication Therapy Management 23
  3. 3. 3.4.3 Shifting Gears - mHealth Leveraging Smart Phones and Personal Devices 263.4.4 Rising Prominence of Social Media and Online Networking 283.4.5 Healthcare Collaboration across Continuum of Care 304 Patient Adherence, Communication and Engagement (PACE) - Role of Collaborations 314.1 Key Stakeholders in Patient Adherence and Engagement Initiatives 314.1.1 Patient Engagement Efforts of Pharmaceutical Industry 314.1.2 Healthcare Providers 324.1.3 Health Plans 324.2 Examples of Successful Industry Collaborations 334.2.1 Employer Diabetes Program in Collaboration with Healthcare Providers and Drug MakerAchieves Patient Engagement 334.2.2 Community-wide Preventive and Disease Management Initiative by Multiple StakeholderAlliance 344.2.3 Manufacturers Collaborate with Payers to Use Claims Data for New Drug Discovery 364.2.4 Integrated Social Media Campaign in Partnership with Patient Groups 365 Patient Adherence, Communication and Engagement (PACE) - Technology as Enabler 385.1 Healthcare IT in Promoting Adherence 385.1.1 EHR and Health Data in Monitoring and Tailoring Adherence Programs 385.1.2 PHR as a Tool to Engage Patients in Self-management 395.1.3 Technology Integration - Personal and Home Health Devices 405.1.4 Engaging Physicians and Patients with mHealth 405.1.5 Social Media Campaigns by Health Organizations and Pharmaceuticals 415.2 Case Studies - Technology Solutions Utilized in Engagement and Adherence Initiatives 435.2.1 Leveraging Existing Data from EHR for Driving Adherence Interventions 435.2.2 Engaging with the Diabetes Community through Social Media 475.2.3 Personal Devices to Promote Patient Engagement in Healthcare 505.2.4 Utilizing a Combination of Technologies for Engaging Patients in Self-management 535.2.5 Integrating Data Captured by Home Health Devices with EMR 556 Patient Adherence, Communication and Engagement (PACE) - Conclusions 576.1 Collaboration is Critical for Success in Adherence Initiatives 576.2 Technology as an Enabler for Improving Adherence 577 Patient Adherence, Communication and Engagement (PACE) - Appendix 597.1 Market Definition 597.2 Abbreviations 597.3 References 607.4 Research Methodology 657.4.1 Coverage 657.4.2 Secondary Research 657.4.3 Primary Research 657.4.4 Expert Panel Validation 667.5 Contact Us 667.6 Disclaimer 66
  4. 4. 1.1 List of TablesTable 1: PACE Industry Drivers, Challenges and Opportunities, 2012 11Table 2: PACE, % of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions andAge, 2008 15Table 3: PACE, Distribution of Medicare FFS Beneficiaries, The US, by Number of ChronicConditions and Healthcare Utilization, 2008 16Table 4: PACE, Mean Expenses per Person with Healthcare Expenses, The US, by Service Type,($) 2009 17Table 5: PACE, Active Prescribers Using EHRs vs. Standalone E-prescribing Systems, The US,(%), 2008-2011 22Table 6: PACE, Written Summaries Provided to Beneficiaries, The US, by % of MTM Programs,2010-2011 24Table 7: PACE, Beneficiary Interventions, The US, % of MTM Programs, 2010-2011 25Table 8: PACE, Provider of MTM Services, The US, by % of MTM Programs, 2010-2011 26Table 9: PACE, Subscriber Base per 100 Inhabitants, The US, by ICT Type, 2006-2011 27Table 10: PACE, Social Media Presence, the US, by Hospital, 2012 28Table 11: PACE, Diabetes Prevention Program, Program Outcomes, 2012 35Table 12: PACE, Adult Asthma Prevalence, Michigan, by Age, 2008 44Table 13: PACE, Michigan, Child Asthma Prevalence, by Age, 2008 44Table 14: PACE, Diabetes Therapeutics Market, The US, Revenue ($bn), 2003-2010 47Table 15: PACE, Diabetes Therapeutics Market, The US, Revenue Forecasts ($bn), 2010-2017 48Table 16: PACE, Multi-channel Diabetes Campaign, Social Media Components, 2009-2012 48Table 17: PACE, Multi-channel Diabetes Campaign, Social Media Performance, 2009-2012 49Table 18: PACE, Adults with Diagnosed Diabetes, Georgia, % by Age, 2001-2010 51Table 19: PACE, Diabetes Treatment Program, Technologies, 2008 53Table 20: PACE, Hypertension Control Intervention, Technologies, 2012 54Table 21: PACE, Hypertension Control Initiative, Technologies, 2012 561.2 List of FiguresFigure 1: PACE Industry Drivers, 2012 10Figure 2: PACE, % of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions andAge, 2008 14Figure 3: PACE, Distribution of Medicare FFS Beneficiaries, The US, by Number of ChronicConditions and Healthcare Utilization, 2008 15Figure 4: PACE, Mean Expenses per Person with Healthcare Expenses, The US, by ServiceType, ($), 2009 17Figure 5: PACE, National Health Spending, The US, by Sponsors, ($tn), 2010 18Figure 6: PACE, Active Prescribers Using EHRs vs. Standalone E-prescribing Systems, The US,(%), 2008-2011 22Figure 7: PACE, Written Summaries Provided to Beneficiaries, The US, by % of MTM Programs,2010-2011 23
  5. 5. Figure 8: PACE, Beneficiary Interventions, The US, % of MTM Programs, 2010-2011 24Figure 9: PACE, Provider of MTM Services, The US, by % of MTM Programs, 2010-2011 25Figure 10: PACE, Subscriber Base per 100 Inhabitants, the US, by ICT Type, 2006-2011 26Figure 11: PACE, FDA Guidelines on Responding to Unsolicited Information on Social Media, theUS, 2011 29Figure 12: PACE, Diabetes Care Program, Program Outcomes, 2007–2009 34Figure 13: PACE, Pain Awareness Raising Initiative in Partnership with Patient Groups, Global,2010 37Figure 14: PACE, Adult Asthma Prevalence, Michigan, by Age, 2008 43Figure 15: PACE, Child Asthma Prevalence, Michigan, by Age, 2008 44Figure 16: PACE, Asthma Wellness Program, Program Outcomes, 2012 46Figure 17: PACE, Diabetes Therapeutics Market, The US, Revenue Forecasts ($bn), 2003-201747Figure 18: PACE, Adults With Diagnosed Diabetes, Georgia, % by Age, 2001-2010 51Figure 19: PACE, Diabetes Treatment Program, Program Outcomes, 2008 52Figure 20: PACE, Hypertension Control Initiative, Program Outcomes, 2012 56Contact: sales@reportsandreports.com for more information.

×